It has been shown that murine CXCL10-producing CD103+ DCs are important in effector T-cell navigation to the tumour, and when these cells are no longer present in the TME, an efficient anti-tumour immunity is lacking [58]. The gene discussed is CXCL10; the disease is neoplasm.